Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,219 | 22,405 | 20,486 | 21,900 | 15,044 |
| Marketable Securities | N/A | N/A | 7,914 | 8,775 | 20,422 |
| Receivables | 6,524 | 5,667 | 4,561 | 3,422 | 3,523 |
| Inventories | 10,478 | 5,069 | 4,688 | 3,897 | 3,488 |
| TOTAL | $28,194 | $33,718 | $39,096 | $40,320 | $43,983 |
| Non-Current Assets | |||||
| PPE Net | 37,065 | 35,502 | 31,398 | 29,518 | 24,334 |
| Investments And Advances | 807 | 522 | 578 | 578 | 574 |
| Intangibles | 28,337 | 28,433 | 28,529 | 28,625 | 28,721 |
| Other Non-Current Assets | 10,000 | 0 | 0 | 0 | 0 |
| TOTAL | $76,209 | $64,457 | $60,505 | $58,721 | $53,629 |
| Total Assets | $104,403 | $98,175 | $99,601 | $99,041 | $97,612 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 861 | 232 | 232 | 232 | 232 |
| Accounts payable and accrued liabilities | 7,529 | 4,072 | 4,304 | 5,721 | 3,996 |
| Accrued Expenses | 10,859 | 5,858 | 4,977 | 4,224 | 3,575 |
| TOTAL | $23,248 | $13,853 | $9,579 | $10,177 | $7,803 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,105 | 6,695 | 6,752 | 6,796 | 6,868 |
| Deferred Revenues | N/A | 3,691 | 66 | N/A | N/A |
| Other Non-Current Liabilities | 29,500 | 31,690 | 31,252 | 30,814 | 30,376 |
| TOTAL | $40,091 | $39,987 | $40,688 | $37,711 | $37,361 |
| Total Liabilities | $63,339 | $53,840 | $50,267 | $47,888 | $45,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,751 | 47,871 | 47,760 | 47,218 | N/A |
| Common Shares | 479 | 478 | 477 | 472 | 466 |
| Retained earnings | -90,342 | -86,871 | -81,661 | -75,723 | -70,302 |
| Other shareholders' equity | -158 | -322 | -497 | -553 | -673 |
| TOTAL | $41,064 | $44,335 | $49,334 | $51,153 | $52,448 |
| Total Liabilities And Equity | $104,403 | $98,175 | $99,601 | $99,041 | $97,612 |